Monthly Archives: February 2012

Bard Peripheral Vascular, Inc. et al. v. W.L. Gore & Associates, Inc.

Posted on February 28, 2012 by Patrick J. Halloran, Ph.D., J.D.

Docket No. 2010-1050 NEWMAN(d), GAJARSA, LINN February 10, 2012 Brief summary: Bard won enhanced damages and attorney’s fees in case stretching back to the 1970s. A key issue was inventorship, which the FC affirmed was achieved by Bard even though … Continue reading →

Posted in Anticipation (35 USC 102), Attorney's Fees, Obviousness, Willfullness, Written description | Leave a comment

AstraZeneca Pharmaceuticals LP et al. v. Apotex Corp. et al.

Posted on February 15, 2012 by Patrick J. Halloran, Ph.D., J.D.

Docket No. 2011-1182, -1183, -1184, -1185, -1186, -1187, -1188, -1189, -1190 RADER, LOURIE, MOOORE February 9, 2012 Subject matter: Generics, ANDA Brief Summary: Filing an ANDA for a drug having any patented use does not automatically constitutes infringement under § … Continue reading →

Posted in Generics / ANDA | Leave a comment